Authors



Fiona Imarhia, PharmD, BCPS

Latest:

Oral Semaglutide for the Management of Type 2 Diabetes Mellitus

Some pertinent information pharmacists should know about oral semaglutide


Jay Paul Singh, PharmD

Latest:

THE PHARMACEUTICAL INDUSTRY: CONTRIBUTING TO BETTER MEDICINES

Drs. Patel, Singh, and Whalen are postdoctoral fellows in the Rutgers Pharmaceutical Industry Fellowship Program. Dr. Alexander is director of the Institute for Pharmaceutical Industry Fellowships, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey. Dr. Barone is professor and chair of the Department of Pharmacy Practice and Administration, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey.



Brandon Martinez, PharmD, BCPS

Latest:

Case Studies (October 2017)

What should these pharmacists do?


Brice Labruzzo Mohundro, PharmD

Latest:

Gout

Gout is a chronic, inflammatory form of arthritis that is increasing in prevalence in the United States. There are a variety of pharmacologic and nonpharmacologic options for treating and preventing flares of gout.


Natalie Stilwell, DVM, MS, PhD

Latest:

Survey Asks Pharmacists About Potential Pet Poisons

A recent survey evaluated the baseline knowledge of licensed pharmacists with regard to common pet toxins.


Ana C. Quinones-Boex, PhD

Latest:

The Road Less Traveled: Nontraditional Work Arrangements in Academia

According to the 2014 National Pharmacist Workforce Study, approximately 18.7% of women and 16.4% of men actively engaged as pharmacists reported working part-time.


Omar Serna, PharmD, BCACP

Latest:

Medicare Part D Insulin Tiering Change: Impact on Health Outcomes

This study explores the impact of a Medicare Part D formulary tier change, specifically with respect to branded insulin products, on insulin adherence, hemoglobin A1C, and diabetes-related events in elderly diabetic beneficiaries strategies for selection of appropriate and cost-effective therapy will also be discussed.


Sara Grossman, PharmD

Latest:

To Substitute or Not to Substitute: That Is the Question

With generic prescriptions on the rise, every pharmacist needs a through understanding of therapeutic equivalence and the generic approval process.


Myrl Weinberg, CAE

Latest:

Developing Optimal Patient Medication Information

Patient medication information should be the most critical information in a patient-friendly format so that individuals can make the most informed decisions about their drugs.


Stephen E. Jones, MD

Latest:

Cost-Effectiveness of Docetaxel-Cyclophosphamide Versus Doxorubicin-Cyclophosphamide for Breast Cancer

Compared with doxorubicin plus cyclophosphamide, docetaxel plus cyclophosphamide was highly cost-effective for adjuvant treatment of operable breast cancer.


Yesenia Prados, PharmD

Latest:

Pharmacists in ACOs Part 3: Chronic Care Management, Chronic Disease State Management, and Transition of Care

After discussing the Basics of Accountable Care Organizations and Medication Therapy Management and Annual Wellness Visit services, the third and last section of the Pharmacists in ACOs series will focus on 3 more integration strategies for pharmacists within the ACO setting, including chronic care management, chronic disease state management, and transitions of care.


Rochelle F. Fu, PhD

Latest:

Impact of Medicaid Preferred Drug List on Long-Acting Opioid Users

An opioid preferred drug list was not associated with an increase in emergency department visits or hospitalizations in a Medicaid population.


Alberto Coustasse, PhD, MD, MBA, MPH

Latest:

How Do Pharmacies Evaluate Cleanroom Automation Systems?

Check out these pre- and postimplementation checklists, which also help to justify the investment.



Troy W. Stubbings, PharmD

Latest:

Telepharmacy and Its Impact on Formulary Adherence

Telepharmacy is comparable to usual care in transitioning members new to an HMO onto formulary medications.


Christina M. Davis, PharmD

Latest:

Understanding the Evolving Landscape of Malignant Melanoma

This Continuing Education activity is supported by an educational grant from Merck Sharpe & Dohme Corp.



Jean-Pierre Garnier, PhD, RPh

Latest:

Media Hype Leaves Doctors Confused, Patients Frightened over Avandia

Dr. Garnier is the chief executive officer of GlaxoSmithKline.



Susan E. Funk, MBA

Latest:

Implementing Guideline-Recommended Therapy for Patients With CKD: Is Hope on the Horizon?

This commentary addresses the possible reasons for treatment gaps between recommended therapy for patients with CKD, and the realities of current practices, and examines new developments that may bridge the gap.




Sean Shampansky, PharmD Candidate

Latest:

Successful Implementation of Student-Driven Virtual Transitions of Care Model During the COVID-19 Pandemic

Virtual transitions of care services are a valuable and viable opportunity for students to progress to graduation and gain valuable experience in preparation for professional employment.


Tarek Hassanein, MD

Latest:

Hepatitis C Management: How Payers, Providers, and Pharmacies Can Work Together to Stem Costs

New models of collaboration can guide providers in optimizing care for patients with HCV.


Jerry Buller, Chief Pharmacy Officer, Trellis Rx

Latest:

How Clinic-Based Specialty Pharmacy Services Strengthen Health Systems of Every Size

The significant jump in hospital-owned specialty pharmacies bolsters the belief that health system leaders increasingly understand how these services enable their organizations to enhance patient care and achieve market differentiation.


Joe Cappello, Senior Vice President of Global Specialty & Branded Product Strategy & Access, AmerisourceBergen

Latest:

Distributors Reveal the Road Map to Successful Specialty Therapy Launches

A strong partnership can support the successful commercialization of a product, position the therapy to meet a manufacturer’s business goals, and provide patients with an option to improve their health and quality of life.



Gene Boerger

Latest:

Minority Report: Using Big Data to Anticipate Patient Behavior

By leveraging analysis of "Big Data," pharmacies can extend their ability to serve a key role in primary care.